Pharmaceuticals, Biotechnology and Life Sciences
Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor Types LATHAM, N.Y.–(BUSINESS…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–#AI–Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry, and AI to discover small molecule therapeutics for age-related…
New chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole…
Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂A, pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects…
BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a…
EMERYVILLE, Calif.–(BUSINESS WIRE)–$OABI #OABI—OmniAb, Inc. (NASDAQ: OABI) will report financial results for the quarter and year ended December 31, 2025,…
WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization…
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions…
Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#ai–VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved…